Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms

PURPOSE: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase 3 clinical development for glaucoma treatment. We investigated the effects of its active metabolite, netarsudil-M1, on outflow facility (C), outflow hydrodynamics, and morphology of the conventional outflow p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Invest Ophthalmol Vis Sci
Main Authors: Ren, Ruiyi, Li, Guorong, Le, Thuy Duong, Kopczynski, Casey, Stamer, W. Daniel, Gong, Haiyan
Format: Artigo
Sprog:Inglês
Udgivet: The Association for Research in Vision and Ophthalmology 2016
Fag:
Glaucoma
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114035/
https://ncbi.nlm.nih.gov/pubmed/27842161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.16-20189
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker